resiquimod has been researched along with cp 105696 in 1 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (cp 105696) | Trials (cp 105696) | Recent Studies (post-2010) (cp 105696) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 33 | 1 | 6 |
| Protein | Taxonomy | resiquimod (IC50) | cp 105696 (IC50) |
|---|---|---|---|
| Leukotriene B4 receptor 1 | Homo sapiens (human) | 0.1131 | |
| Leukotriene B4 receptor 2 | Homo sapiens (human) | 0.2192 | |
| Cysteinyl leukotriene receptor 2 | Homo sapiens (human) | 0.0084 | |
| Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | 0.0084 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borgeat, P; Flamand, L; Gravel, A; Lefebvre, JS; Lévesque, T; Paré, G; Picard, S | 1 |
1 other study(ies) available for resiquimod and cp 105696
| Article | Year |
|---|---|
Extra domain A of fibronectin primes leukotriene biosynthesis and stimulates neutrophil migration through activation of Toll-like receptor 4.
Topics: Animals; Anti-Inflammatory Agents; Benzopyrans; Carboxylic Acids; Cytokines; Female; Fibronectins; Humans; Imidazoles; Leukotriene B4; Leukotrienes; Lipopeptides; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Monocytes; Neutrophils; Protein Isoforms; Pyrrolidines; Recombinant Proteins; Sulfonamides; Toll-Like Receptor 4; Transendothelial and Transepithelial Migration | 2011 |